| Primary |
| Acute Coronary Syndrome |
15.1% |
| Prophylaxis |
9.7% |
| Hyperlipidaemia |
8.6% |
| Hypertension |
8.6% |
| Dyslipidaemia |
7.5% |
| Hypercholesterolaemia |
7.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.4% |
| Atrial Flutter |
4.3% |
| Diabetes Mellitus |
4.3% |
| Ischaemic Cardiomyopathy |
4.3% |
| Agitation |
3.2% |
| Angina Pectoris |
3.2% |
| Lipid Metabolism Disorder |
3.2% |
| Acute Myocardial Infarction |
2.2% |
| Analgesia |
2.2% |
| Anxiety |
2.2% |
| Cerebrovascular Accident |
2.2% |
| Depression |
2.2% |
| Hypothyroidism |
2.2% |
| Renal Transplant |
2.2% |
|
| Rhabdomyolysis |
18.8% |
| Hepatitis Cholestatic |
12.5% |
| Drug Interaction |
9.4% |
| Erectile Dysfunction |
6.3% |
| Ichthyosis |
6.3% |
| Autoimmune Hepatitis |
3.1% |
| Blood Pressure Increased |
3.1% |
| Decreased Appetite |
3.1% |
| Drug Eruption |
3.1% |
| Dyspnoea |
3.1% |
| Ecchymosis |
3.1% |
| Face Oedema |
3.1% |
| Hypoglycaemia |
3.1% |
| Hyponatraemia |
3.1% |
| Malaise |
3.1% |
| Muscle Spasms |
3.1% |
| Neuropathy Peripheral |
3.1% |
| Neurosis |
3.1% |
| Pancreatitis Acute |
3.1% |
| Paraesthesia |
3.1% |
|
| Secondary |
| Hypertension |
31.4% |
| Drug Use For Unknown Indication |
11.4% |
| Diabetes Mellitus |
8.6% |
| Atrial Fibrillation |
7.1% |
| Acute Coronary Syndrome |
5.7% |
| Back Pain |
5.7% |
| Hypercholesterolaemia |
4.3% |
| Hyperlipidaemia |
4.3% |
| Arthritis |
2.9% |
| Dyspepsia |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Agitation |
1.4% |
| Amnesia |
1.4% |
| Anaemia |
1.4% |
| Angina Pectoris |
1.4% |
| Arrhythmia |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Blood Triglycerides Increased |
1.4% |
| Blood Uric Acid Increased |
1.4% |
| Cardiac Disorder |
1.4% |
|
| Pancreatitis Acute |
31.6% |
| Transient Ischaemic Attack |
15.8% |
| Ichthyosis |
10.5% |
| Lichenoid Keratosis |
10.5% |
| Decreased Appetite |
5.3% |
| Hepatitis Acute |
5.3% |
| Hepatitis Cholestatic |
5.3% |
| Pruritus |
5.3% |
| Syncope |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
|
| Concomitant |
| Hypertension |
21.1% |
| Drug Use For Unknown Indication |
13.5% |
| Type 2 Diabetes Mellitus |
8.8% |
| Dyslipidaemia |
6.6% |
| Osteoporosis |
6.0% |
| Breast Cancer |
4.4% |
| Diabetes Mellitus |
4.1% |
| Prophylaxis |
4.1% |
| Atrial Fibrillation |
3.8% |
| Post Herpetic Neuralgia |
3.8% |
| Hypercholesterolaemia |
3.5% |
| Essential Hypertension |
2.8% |
| Pain |
2.8% |
| Renal Transplant |
2.8% |
| Cardiac Disorder |
2.2% |
| Coronary Artery Disease |
2.2% |
| Cardiovascular Event Prophylaxis |
1.9% |
| Colorectal Cancer Metastatic |
1.9% |
| Hyperlipidaemia |
1.9% |
| Insomnia |
1.9% |
|
| Vomiting |
8.5% |
| Hepatitis Acute |
6.8% |
| Renal Failure |
6.8% |
| Renal Tubular Necrosis |
6.8% |
| Thrombocytopenia |
6.8% |
| Drug Ineffective |
5.1% |
| Feeling Abnormal |
5.1% |
| Gait Disturbance |
5.1% |
| Lactic Acidosis |
5.1% |
| Pyelonephritis |
5.1% |
| Pyrexia |
5.1% |
| Renal Failure Acute |
5.1% |
| Superior Vena Caval Occlusion |
5.1% |
| Aphasia |
3.4% |
| Blood Creatine Phosphokinase Increased |
3.4% |
| Coagulopathy |
3.4% |
| Haemoptysis |
3.4% |
| Hyponatraemia |
3.4% |
| Hypovolaemic Shock |
3.4% |
| Ileus Paralytic |
3.4% |
|
| Interacting |
| Acute Coronary Syndrome |
54.8% |
| Agitation |
12.9% |
| Angina Pectoris |
12.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.3% |
| Amnesia |
8.1% |
|
| Syncope |
42.9% |
| Hepatitis Cholestatic |
35.7% |
| Drug Interaction |
14.3% |
| Hepatitis Toxic |
7.1% |
|
